cobalt has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, C; Hoenig, MR; Sellke, FW | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG | 1 |
| Khlebopros, RG; Morgulis, II; Pahomova, VG; Rupenko, AP; Shadrin, KV | 1 |
| Asano, T; de Winter, RJ; Dijkstra, J; Jonker, H; Katagiri, Y; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Stone, GW; Tanabe, K; Tenekecioglu, E; Wykrzykowska, JJ | 1 |
| Fusazaki, T; Hayashi, T; Hibi, K; Ishihara, S; Ito, Y; Kataoka, T; Kikuchi, T; Kuriyama, N; Morino, Y; Morita, T; Otake, H; Otsuka, Y; Shinke, T; Suzuki, T; Tanabe, K; Tanaka, H; Terashita, D | 1 |
1 review(s) available for cobalt and cardiovascular agents
| Article | Year |
|---|---|
Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis.
Topics: Angiogenic Proteins; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cell Hypoxia; Cell Movement; Chemokine CXCL12; Cobalt; Endothelial Cells; Gene Expression; Humans; Hydralazine; Hypoxia-Inducible Factor 1, alpha Subunit; Monocytes; Myocardial Infarction; Neovascularization, Physiologic; Oxygen; Receptors, CXCR4; Risk Factors; Signal Transduction; Stem Cell Transplantation; Stem Cells; Wound Healing | 2008 |
1 trial(s) available for cobalt and cardiovascular agents
| Article | Year |
|---|---|
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States | 2009 |
3 other study(ies) available for cobalt and cardiovascular agents
| Article | Year |
|---|---|
Characteristics of oxygen transport through the surface of the isolated perfused rat liver.
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Cardiovascular Agents; Cobalt; Computer Simulation; Diffusion; In Vitro Techniques; Liver; Male; Models, Biological; Oxygen; Oxygen Consumption; Rats, Wistar | 2015 |
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Topics: Absorbable Implants; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sirolimus | 2017 |
Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of st-elevation myocardial infarction: results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study).
Topics: Aged; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Tomography, Optical Coherence; Treatment Outcome | 2019 |